EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Angioimmunoblastic T-cell lymphoma following Castleman’s disease: diagnostic challenges and literature review

Ruyi Xu, Xi Huang, Jia Hu, Jinuo Wang, Duoduo Zhao, Xiaoyan Han, Zhen Cai, Wenjun Wu

Annals of Hematology · 28.07.2026 · 105 (11)

DOI: 10.1007/s00277-026-07199-3 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Annals of Hematology, online erschienen am 28.07.2026. Verfasst von Ruyi Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, No. 79, Qingchun Road, Hangzhou, 310006, …. Hauptthemen laut MEDLINE: Castleman Disease, Lymphoma, T-Cell, Immunoblastic Lymphadenopathy. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Castleman disease (CD) represents a heterogeneous group of hematologic disorders characterized by distinct histopathological features. While CD is regarded as a pre-lymphomatous condition, its reactive or neoplastic nature is still a matter of controversy. Although rare, lymphoma has been reported in patients with CD, most commonly B-cell lymphomas. Here, we present a case of a 69-year-old man initially diagnosed with CD who subsequently developed angioimmunoblastic T-cell lymphoma (AITL) during treatment. To elucidate the potential biological relationship between these two disease entities, we performed whole-exome sequencing to compare genomic alterations between the two disease states. Additionally, we provide a concise review of published cases documenting lymphoma occurring after or coexisting with CD, summarizing patients' characteristics and the various treatment strategies employed thus far.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Castleman DiseaseLymphoma, T-CellImmunoblastic LymphadenopathyHumansMaleAgedAntineoplastic Combined Chemotherapy Protocols

Stichwörter der Autor:innen

Angioimmunoblastic T-cell lymphomaCastleman’s diseaseGenomic alterationsLymphoma development; immune dysregulation

Autor:innen und Institutionen

  • Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, No. 79, Qingchun Road, Hangzhou, 310006, China.
  • Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, No. 79, Qingchun Road, Hangzhou, 310006, China. wenjun96@zju.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Xu, R., Huang, X., Hu, J., Wang, J., Zhao, D., Han, X., Cai, Z., & Wu, W. (2026). Angioimmunoblastic T-cell lymphoma following Castleman’s disease: diagnostic challenges and literature review. Annals of Hematology, 105(11). https://doi.org/10.1007/s00277-026-07199-3

Vancouver

Xu R, Huang X, Hu J, Wang J, Zhao D, Han X, et al. Angioimmunoblastic T-cell lymphoma following Castleman’s disease: diagnostic challenges and literature review. Annals of Hematology. 2026;105(11). doi:10.1007/s00277-026-07199-3

BibTeX
@article{Xu2026,
  author = {Xu, Ruyi and Huang, Xi and Hu, Jia and Wang, Jinuo and Zhao, Duoduo and Han, Xiaoyan and Cai, Zhen and Wu, Wenjun},
  title = {Angioimmunoblastic T-cell lymphoma following Castleman’s disease: diagnostic challenges and literature review},
  journal = {Annals of Hematology},
  year = {2026},
  volume = {105},
  number = {11},
  doi = {10.1007/s00277-026-07199-3}
}
Kostenlos starten →